| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 31 |
| 1 | DARBEPOETIN ALFA | 17 |
| 2 | FOLIC ACID | 9 |
| 3 | TACROLIMUS | 9 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| 5 | TACROLIMUS OINTMENT 0.1% | 9 |
| 6 | HYDROXYUREA | 8 |
| 7 | VOXELOTOR | 8 |
| 8 | ACETAMINOPHEN | 6 |
| 9 | EPOETIN ALFA | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHACRYNIC ACID | 1 | 0.0018 |
| 1 | MITAPIVAT | 2 | 0.0015 |
| 2 | CRIZANLIZUMAB | 2 | 0.0014 |
| 3 | CAPLACIZUMAB | 2 | 0.0011 |
| 4 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 5 | ECULIZUMAB | 31 | 0.0006 |
| 6 | FELBAMATE | 1 | 0.0006 |
| 7 | PEGCETACOPLAN | 1 | 0.0005 |
| 8 | EPOETIN ALFA | 6 | 0.0005 |
| 9 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Complement Inhibitor [EPC] | 31 |
| 1 | Erythropoiesis-stimulating Agent [EPC] | 17 |
| 2 | Vitamin C [EPC] | 10 |
| 3 | Vitamin B12 [EPC] | 9 |
| 4 | Vitamin D [EPC] | 9 |
| 5 | Antimetabolite [EPC] | 8 |
| 6 | Hemoglobin S Polymerization Inhibitor [EPC] | 8 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 8 | Corticosteroid [EPC] | 7 |
| 9 | Proton Pump Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Pyruvate Kinase Activator [EPC] | 2 | 0.0015 |
| 1 | Selectin Blocker [EPC] | 2 | 0.0014 |
| 2 | Complement Inhibitor [EPC] | 31 | 0.0006 |
| 3 | Hemoglobin S Polymerization Inhibitor [EPC] | 8 | 0.0004 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 17 | 0.0003 |
| 5 | Vitamin D3 Analog [EPC] | 4 | 0.0002 |
| 6 | Iron Chelator [EPC] | 4 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 3 | 0.0001 |